Andrea Szegedi
Overview
Explore the profile of Andrea Szegedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1041
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Molnar P, Demeny M, Varkonyi B, Polgar Z, Por A, Kovacs I, et al.
Front Pharmacol
. 2025 Mar;
16:1519066.
PMID: 40046735
Background: Considering the role PARPs play in inflammation, we assessed the effect of PARP inhibition in an inflammatory skin condition, psoriasis, to explore novel avenues for the potential repurposing of...
2.
Benezeder T, Bordag N, Woltsche J, Falkensteiner K, Graier T, Schadelbauer E, et al.
J Allergy Clin Immunol
. 2025 Feb;
PMID: 39978684
Background: Due to similarities, the distinction between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP) has been a matter of debate for a long time. Objectives: Our aim...
3.
Thaci D, Ohtsuki M, Maul J, Szegedi A, Luna P, Lynde C, et al.
Dermatol Ther (Heidelb)
. 2025 Feb;
15(2):381-394.
PMID: 39904971
Introduction: Risankizumab is approved for treating moderate-to-severe psoriasis. This interim analysis at 25 months evaluated the effectiveness of risankizumab compared with other approved biologics (OtherBios) among patients with moderate-to-severe psoriasis...
4.
Szegedi A, Komlosi Z, Kapitany A, Bata-Csorgo Z, Koncz G, Bacsi A
Allergy
. 2025 Jan;
PMID: 39873245
No abstract available.
5.
Balazs P, Gaspar K, Gergely H, Hajdu K, Hollo P, Koszoru K, et al.
Arch Dermatol Res
. 2025 Jan;
317(1):291.
PMID: 39825944
This study aims to explore the measurement agreement between direct and indirect health utility measures in four chronic dermatological conditions (atopic dermatitis, hidradenitis suppurativa, pemphigus, psoriasis). Outpatients survey data collected...
6.
Soltesz L, Gaspar K, Kapitany A, Dajnoki Z, Szegedi A
Orv Hetil
. 2024 Oct;
165(41):1602-1612.
PMID: 39396227
No abstract available.
7.
8.
Janka E, Szabo I, Kollar S, Toka-Farkas T, Vanyai B, Varvolgyi T, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272837
Methods: A total of 199 patients with advanced melanoma treated with BRAF + MEK inhibitors were included in our single-center retrospective study. We analyzed the risk of progression and death...
9.
Mammadov Y, Austin J, Shipowick T, Veldman K, Eming S, Szegedi A, et al.
J Invest Dermatol
. 2024 Jul;
144(12):2631-2633.
PMID: 39023473
No abstract available.
10.
Singh P, Gaspar K, Szegedi A, Sajtos L, Barath S, Hevessy Z
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542456
This study investigates the roles of mucosal-associated invariant T (MAIT) cells and Vα7.2/CD161 T cells in skin diseases, focusing on atopic dermatitis. MAIT cells, crucial for bridging innate and adaptive...